MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has issued award SPE2DP26F5781 to DMS Pharmaceutical Group Inc for the procurement of Meloxicam tablets. This contract, dated May 15, 2026, is established as a delivery order under the primary agreement SPE2DX25D9900. The award focuses on the supply of Meloxicam tablets identified by national stock number 6505015413243. This federal procurement is managed by the Department of Defense and was officially posted on the DIBBS platform on August 26, 2026.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
